A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or Inactive virus COVID-19 Vaccines. Lim et. al.

Published: 29 September 2022| Version 1 | DOI: 10.17632/5vhym6h3cy.1
Contributor:
Anthony T. Tan

Description

Supplementary Table 1. Amino acid sequence of SARS-CoV-2 Spike-, Membrane-, Nucleoprotein- and Omicron VOC- peptides used. Related to Figure 1-7.

Files

Institutions

Duke-NUS Medical School

Categories

Virus Peptides

Licence